Jiangsu Hengrui Pharmaceuticals Co Ltd

General

Total Cases6

Active Cases3

Patents1

CourtsD. New Jersey N.D. Illinois

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
01/13/25	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	MOTION by Defendant Fresenius Kabi USA, LLC for extension of time Defendant's Unopposed Motion to Extend Time to Answer or Otherwise Respond to Complaint (Sklar, Steven) (Entered: 01/13/2025)
01/02/25	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	MINUTE entry before the Honorable Steven C. Seeger: Defendant Fresenius Kabi USA, LLC's unopposed motion to extend time to answer or otherwise respond to complaint (Dckt. No. [18] ) is granted. Defendant shall respond to the complaint by January 13, 2025. Mailed notice. (jjr, ) (Entered: 01/02/2025)
01/01/25	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	ANNUAL REMINDER: Pursuant to [Local Rule 3.2 (Notification of Affiliates)][, any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this ][LINK][ will provide additional information. Signed by the Honorable Virginia M. Kendall on 12/20/2024: Mailed notice. (tg, ) (Entered: 01/01/2025)] ANNUAL REMINDER: Pursuant to [Local Rule 3.2 (Notification of Affiliates)][, any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this ][LINK][ will provide additional information. Signed by the Honorable Virginia M. Kendall on 12/20/2024: Mailed notice. (tg, ) (Entered: 01/01/2025)]
12/30/24	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	MOTION by Defendant Fresenius Kabi USA, LLC for extension of time to file answer to Complaint (Sklar, Steven) (Entered: 12/30/2024)
12/30/24	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	ATTORNEY Appearance for Defendant Fresenius Kabi USA, LLC by Steven H. Sklar (Sklar, Steven) (Entered: 12/30/2024)
12/22/24	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	MAILED patent report to Patent Trademark Office, Alexandria VA. (Attachments: # [1] Patents)(aee, ) (Entered: 12/22/2024)
12/17/24	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	MINUTE entry before the Honorable Steven C. Seeger: MINUTE entry before the Honorable Steven C. Seeger: The motion for leave to appear pro hac vice (Dckt. No. [12] ) is granted. Attorney Corrin Nicole Drakulich for Pacira BioSciences, Inc. and Pacira Pharmaceuticals, Inc. Mailed notice. (jjr, ) (Entered: 12/17/2024)
12/12/24	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	SUMMONS Returned Executed by Pacira Pharmaceuticals, Inc., Pacira BioSciences, Inc. as to Fresenius Kabi USA, LLC on 12/10/2024, answer due 12/31/2024. (Fogel, Louis) (Entered: 12/12/2024)
12/11/24	Pacira Pharmaceuticals Inc v. Fresenius Kabi USA LLC 1:24-CV-12416 ( N.D. IL )	AFFIDAVIT of Service filed by Plaintiffs Pacira Pharmaceuticals, Inc., Pacira BioSciences, Inc. regarding Summons, Complaint (with Exhibits A-B) served on Fresenius Kabi USA LLC on 12/10/2024 (Fogel, Louis) (Entered: 12/11/2024)
12/10/24	Evenus Pharmaceutical Laboratories Inc v. Pacira Pharmaceuticals Inc 2:24-CV-11014 ( D. NJ )	Corporate Disclosure Statement by EVENUS PHARMACEUTICAL LABORATORIES, INC., JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. identifying JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. as Corporate Parent. (MURTHA, WILLIAM) Modified on 12/11/2024 (dam). (Entered: 12/10/2024)